In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Trevi Therapeutics Inc’s stock clocked out at $6.74, up 2.43% from its previous closing price of $6.58. In other words, the price has increased by $2.43 from its previous closing price. On the day, 3.05 million shares were traded.
Ratios:
To gain a deeper understanding of TRVI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.38 and its Current Ratio is at 15.38. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on May 28, 2025, initiated with a Buy rating and assigned the stock a target price of $21.
On March 10, 2025, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $9 to $29. Needham reiterated its Buy rating for the stock on March 10, 2025, while the target price for the stock was revised from $8 to $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when SCIASCIA THOMAS sold 2,631 shares for $6.60 per share. The transaction valued at 17,365 led to the insider holds 221,373 shares of the business.
GOOD JENNIFER L sold 5,263 shares of TRVI for $34,625 on Mar 21 ’25. The President & CEO now owns 213,313 shares after completing the transaction at $6.58 per share. On Mar 21 ’25, another insider, GOOD JENNIFER L, who serves as the Officer of the company, bought 5,263 shares for $6.58 each.
Stock Price History:
Over the past 52 weeks, TRVI has reached a high of $7.48, while it has fallen to a 52-week low of $2.30. The 50-Day Moving Average of the stock is 7.13%, while the 200-Day Moving Average is calculated to be 54.25%.
Shares Statistics:
A total of 99.89M shares are outstanding, with a floating share count of 59.67M. Insiders hold about 41.36% of the company’s shares, while institutions hold 51.51% stake in the company.
